ARCpoint Inc
ARC
Minas Metals Ltd
MINA
Quri-Mayu Developments Ltd
QURI
KGL Resources Ltd
KGL.H
Alerio Gold Corp
ALE
CA Stock MarketDetailed Quotes
WELL WELL Health Technologies Corp
- 6.790
- -0.090-1.31%
15min DelayMarket Closed Dec 13 16:00 ET
1.69BMarket Cap21.90P/E (TTM)
7.020High6.730Low1.81MVolume6.910Open6.880Pre Close12.37MTurnover7.02052wk High0.94%Turnover Ratio248.96MShares3.41052wk Low0.31EPS TTM1.30BFloat Cap9.840Historical High0.00P/E (Static)192.18MShs Float0.005Historical Low--EPS LYR4.22%Amplitude--Dividend TTM2.00P/B1Lot Size--Div YieldTTM
WELL Health Technologies Corp Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 190.77%57.88M | 147.39%35.16M | 8.18%19.06M | -13.21%66.44M | -49.35%14.69M | 35.46%19.91M | -26.88%14.21M | 31.51%17.62M | 243.75%76.55M | 244.99%29.01M |
| Net income from continuing operations | -1,590.14%-75.75M | 5,902.38%116.98M | 284.44%19.6M | -10.91%16.64M | 52.88%33.76M | -833.55%-4.48M | -62.06%-2.02M | -282.82%-10.63M | 159.69%18.68M | 596.72%22.08M |
| Operating gains losses | 79.52%903K | 184.55%2.24M | -3,757.58%-8.91M | -223.52%-8.19M | -1,927.04%-5.81M | 117.95%503K | -424.79%-2.65M | 73.14%-231K | -344.21%-2.53M | 150.56%318K |
| Depreciation and amortization | 13.12%17.48M | 23.26%17.31M | 14.03%16.56M | 10.08%60.77M | 18.84%16.76M | 11.00%15.45M | 1.67%14.04M | 8.58%14.52M | 42.61%55.2M | 3.01%14.1M |
| Unrealized gains and losses of investment securities | --77.09M | ---116.33M | ---13.96M | -14,992.20%-42.56M | -13,400.00%-42.56M | --0 | --0 | --0 | ---282K | --320K |
| Remuneration paid in stock | -69.60%2.14M | -22.32%4.77M | -17.00%5.48M | 6.86%26.16M | 29.43%6.39M | 19.72%7.04M | -28.06%6.13M | 28.41%6.6M | 16.52%24.48M | 15.74%4.93M |
| Deferred tax | 53.15%-759K | -26.35%-6.77M | 67.01%-1.02M | -965.54%-10.42M | ---351K | ---1.62M | ---5.36M | ---3.09M | ---978K | ---- |
| Other non cashItems | -1.87%4.25M | -59.65%2.37M | -55.75%6.01M | 364.85%34.29M | 146.88%10.49M | -1.14%4.33M | 176.92%5.88M | 364.60%13.59M | -416.12%-12.95M | -995.32%-22.37M |
| Change In working capital | 2,568.29%32.53M | 902.80%14.6M | -49.89%-4.7M | -101.75%-10.25M | -137.52%-3.98M | 81.93%-1.32M | 60.38%-1.82M | 17.55%-3.13M | 55.04%-5.08M | 252.25%10.61M |
| -Change in receivables | -815.16%-35.34M | -950.33%-51.68M | -667.50%-28.6M | 73.48%-2.49M | -145.25%-9.78M | 147.35%4.94M | 147.54%6.08M | 51.97%-3.73M | 38.38%-9.37M | 384.40%21.61M |
| -Change in inventory | 54.04%-74K | -411.16%-669K | 121.43%6K | 132.93%190K | 368.57%164K | 60.34%-161K | 321.65%215K | 74.31%-28K | -165.87%-577K | 116.67%35K |
| -Change in prepaid assets | ---- | ---- | ---- | 70.98%-2.28M | ---- | ---- | ---- | ---- | ---7.87M | ---- |
| -Change in payables and accrued expense | 334.87%4.64M | 162.32%6.49M | 163.16%6.62M | -187.28%-9.21M | 126.96%665K | -147.09%-1.98M | -172.96%-10.42M | 146.14%2.52M | 215.80%10.55M | -203.61%-2.47M |
| -Change in other current assets | 99.63%-20K | -58.76%-4.88M | -133.45%-1.23M | 50.99%-1.24M | 213.73%3.64M | -5,779.57%-5.47M | 7.41%-3.07M | -10.11%3.66M | -209.78%-2.53M | -62.45%-3.2M |
| -Change in other current liabilities | 5,544.57%64.97M | 1,106.39%63.48M | 418.80%18.25M | 18.97%4.94M | 353.61%4.25M | 198.96%1.15M | 48.43%5.26M | -401.10%-5.72M | 304.48%4.15M | 57.58%-1.68M |
| -Change in other working capital | -945.88%-1.64M | 1,517.39%1.86M | 50.30%251K | -128.06%-158K | -115.19%-634K | 120.64%194K | 101.85%115K | -95.29%167K | 208.69%563K | -4.77%4.17M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 190.77%57.88M | 147.39%35.16M | 8.18%19.06M | -13.21%66.44M | -49.35%14.69M | 35.46%19.91M | -26.88%14.21M | 31.51%17.62M | 243.75%76.55M | 244.99%29.01M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 91.42%-5.28M | -174.88%-6M | 60.75%-5.81M | -114.40%-81.32M | 6.87%-12.92M | -7,677.61%-61.61M | 142.25%8.01M | -150.04%-14.8M | 92.41%-37.93M | 68.29%-13.87M |
| Net PPE purchase and sale | -60.94%-3.91M | -168.04%-4.74M | 19.36%-1.61M | -26.59%-8.11M | -9.53%-1.91M | 6.82%-2.43M | -80.96%-1.77M | -85.95%-2M | -138.78%-6.4M | 4.60%-1.74M |
| Net business purchase and sale | 97.56%-1.12M | -36.62%6.39M | 47.27%-6.49M | -340.93%-72.78M | -266.69%-24.72M | -462.18%-45.84M | 157.05%10.09M | -159.42%-12.31M | 96.09%-16.51M | 85.81%-6.74M |
| Net investment purchase and sale | --0 | --0 | --2.39M | -29.96%11.56M | --125K | --0 | --11.44M | --0 | --16.51M | --0 |
| Net other investing changes | 98.13%-250K | 34.89%-7.65M | 80.57%-95K | 61.96%-11.99M | 352.13%13.58M | 48.20%-13.34M | -3,842.28%-11.75M | -398.98%-489K | 58.15%-31.53M | -1,525.13%-5.39M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 91.42%-5.28M | -174.88%-6M | 60.75%-5.81M | -114.40%-81.32M | 6.87%-12.92M | -7,677.61%-61.61M | 142.25%8.01M | -150.04%-14.8M | 92.41%-37.93M | 68.29%-13.87M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -168.18%-32.48M | -11.49%-31.04M | 2.82%-9.74M | 120.11%10.63M | 104.57%854K | 325.06%47.63M | -236.92%-27.84M | 69.96%-10.02M | -111.68%-52.85M | -131.90%-18.67M |
| Net issuance payments of debt | -146.51%-24.82M | -7.60%-20.82M | -70.76%-4.94M | 165.99%38.77M | 173.57%7.63M | 448.86%53.38M | -324.30%-19.35M | 89.87%-2.89M | -134.34%-58.75M | -115.64%-10.37M |
| Net common stock issuance | ---608K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -88.67%34.27M | --0 |
| Cash dividends paid | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | --0 |
| Proceeds from stock option exercised by employees | -83.47%20K | 686.46%2.73M | 106.78%366K | -30.65%810K | 20.44%165K | -70.98%121K | -11.70%347K | -19.91%177K | 85.10%1.17M | -44.08%137K |
| Interest paid (cash flow from financing activities) | --0 | ---- | ---- | 9.09%-3.85M | 0.00%-1.93M | --0 | ---- | ---- | ---4.24M | ---1.93M |
| Net other financing activities | -20.54%-7.07M | -53.02%-10.58M | 29.28%-5.17M | 0.79%-25.1M | 22.93%-5.02M | 6.67%-5.86M | 7.28%-6.92M | -44.68%-7.31M | -16.74%-25.3M | 18.85%-6.51M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -168.18%-32.48M | -11.49%-31.04M | 2.82%-9.74M | 120.11%10.63M | 104.57%854K | 325.06%47.63M | -236.92%-27.84M | 69.96%-10.02M | -111.68%-52.85M | -131.90%-18.67M |
| Net cash flow | ||||||||||
| Beginning cash position | 30.64%46.55M | 15.68%48.23M | -11.21%43.42M | -21.01%48.91M | -19.96%41.97M | -37.62%35.63M | 15.63%41.69M | -21.01%48.91M | -28.74%61.92M | 35.40%52.44M |
| Current changes in cash | 239.04%20.12M | 66.66%-1.87M | 148.92%3.52M | 65.19%-4.95M | 154.62%1.93M | 204.93%5.94M | -126.99%-5.62M | 72.18%-7.2M | 43.05%-14.23M | -115.22%-3.53M |
| Effect of exchange rate changes | -229.53%-522K | 145.18%197K | 2,626.09%581K | -143.75%-532K | -15,966.67%-476K | -58.28%403K | -276.52%-436K | ---23K | 13,411.11%1.22M | 150.00%3K |
| Cash adjustments other than cash changes | --0 | --0 | --703K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| End cash Position | 57.61%66.15M | 30.64%46.55M | 15.68%48.23M | -11.21%43.42M | -11.21%43.42M | -19.96%41.97M | -37.62%35.63M | 15.63%41.69M | -21.01%48.91M | -21.01%48.91M |
| Free cash from | 208.84%53.97M | 144.46%30.43M | 11.70%17.45M | -16.84%58.33M | -53.11%12.79M | 44.59%17.48M | -32.59%12.45M | 26.77%15.62M | 258.12%70.14M | 314.22%27.27M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.